This pattern of responses observed for kaempferol in gastric cancer cells has previously been observed for CDIM/NR4A1 antagonists or NR4A1 silencing in RMS and other cancer cell lines [21–27] and therefore, we hypothesized that kaempferol is an NR4A1 ligand. Here, NR4A1 is linked to cancer.